Paggamit ng Sinovac vaccine sa health workers aprubado na ng IATF | Bandera

Paggamit ng Sinovac vaccine sa health workers aprubado na ng IATF

- February 27, 2021 - 04:37 PM

Photo mula sa UNB via The Daily Star/Asia News Network

Inaprubahan ng Inter-Agency Task Force (IATF) on Emerging Infectious Diseases ang rekomendasyon ng National Immunization Technical Advisory Group (NITAG) na gamitin ang bakuna kontra Covid-19 na gawa ng Sinovac ng China sa mga health workers kahit nasa 50.4 percent lamang ang efficacy rate nito.

Ito ang inihayag ni Health Undersecretary Maria Rosario Vergeire sa virtual briefing.

Ayon kay Vergeire, ipi-presenta kay Pangulong Rodrigo Duterte ang naturang rekomendasyon.

Samantala, sinabi ni Presidential Spokesman Harry Roque na welcome ang naturang rekomendasyon.

“As we have said in many occasions, healthcare workers are the most critical frontliners in our flight against Covid-19 and they remain at the top of our priority list for vaccination. The IATF’s approval of the recommendation of the National Immunization Technical Advisory Group and the Department of Health’s Technical Advisory Group is an assurance that the use of Sinovac is safe and beneficial to our health workers,” pahayag ni Roque.

“The Sinovac vaccine is expected to arrive on Sunday, February 28, and we are confident that many of our healthcare workers would get themselves inoculated to boost public confidence in our mass vaccination program against the coronavirus,” pahayag ni Roque.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Bandera. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

What's trending